Clinical efficacy of dapagliflozin in the treatment of patients with diabetic nephropathy and its effect on albuminuria level

Puntos clave

• Dapagliflozin significantly reduces albuminuria levels in patients with diabetic nephropathy.
• The study observed a notable improvement in kidney function among participants treated with dapagliflozin.
• This research utilized a prospective observational study design to assess the intervention's efficacy.
• The findings highlight the importance of managing albuminuria as part of diabetic nephropathy treatment.